Home » Topics » Ocular, BioWorld Science

Ocular, BioWorld Science
RSS

CA4P enters phase II study

Nov. 23, 2004

ISTA licenses U.S. rights for ecabet sodium for dry eye

Nov. 22, 2004

Disappointing preliminary results of Trabio study

Nov. 12, 2004

Use of diazoxide for treatment of ischemia retinae claimed in CNRS patent

Nov. 11, 2004

New clinical data on the efficacy of SnET2 photodynamic therapy in AMD

Nov. 10, 2004

Anecortave acetate shows efficacy in maintaining visual acuity of patients with wet AMD

Nov. 10, 2004

Long-term benefits of ranibizumab in neovascular AMD patients

Nov. 9, 2004

Inspire licenses novel glaucoma technology

Nov. 9, 2004

Serotonin receptor agonists for treatment of ocular hypertension and glaucoma

Nov. 4, 2004

Series B financing at Othera to accelerate pipeline development

Oct. 27, 2004

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...